Lobular carcinoma of the male breast is rare. We sought to investigate the clinical characteristics, treatment, and outcomes of men and women with lobular breast cancer, using a population-based database.
We reviewed the Surveillance, Epidemiology, and End Results database 1988–2008 and identified patients with a lobular breast cancer diagnosis (invasive lobular carcinoma [ILC] and lobular carcinoma in situ [LCIS]) using the “International Classification of Diseases for Oncology, Third Edition” codes. Bivariate analyses compared the male and female patients on demographics, clinical characteristics, and treatment modalities. Multivariate logistic regression analysis determined the risk-adjusted likelihood of receiving treatment. Survival analysis was done and hazard ratios were obtained using Cox proportional models.
Overall, 133,339 patients were identified, including 133,168 women (99.9%) and 171 men (0.1%). Most had ILC (82.08%). The median age was 66 ± 20 y for the men and 61 ± 21 y for the women. The men with ILC were more likely to have poorly differentiated tumors (26.45% versus 15.61%; P < 0.001) and stage IV disease (9.03% versus 4.18%; P = 0.005) than were the women. The cancer-specific 5-year survival rates for ILC were 82.9% for the men and 91.9% for the women. Adjusted survival was better for patients with ILC receiving surgery plus radiotherapy than patients receiving neither (hazard ratio 0.52, 95% confidence interval 0.49–0.56). Women with ILC had a 55% increased odds of receiving surgery plus radiotherapy compared with men (odds ratio 1.55, 95% confidence interval 1.08–2.22).
ILC presents at a higher grade and stage in men. The difference in disease characteristics and survival rates suggests that the treatment of men with lobular breast cancer should be adjusted to improve their outcomes.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Surgical Research
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Breast cancer in men detailed guide.American Cancer Society, Atlanta2012
- Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival.Ann Epidemiol. 2005; 15: 773
- Invasive lobular carcinoma of the male breast: a case report.Jpn J Clin Oncol. 2001; 31: 444
- Invasive lobular carcinoma of the male breast.Can J Surg. 2006; 49: 365
- Pleomorphic lobular carcinoma in a male breast: a rare occurrence.Pathol Res Int. 2010; 2010: 871369
- Pleomorphic variant of invasive lobular carcinoma of the male breast.Virchows Arch. 2005; 446: 344
- Lobular breast cancer in men: case report and review of the literature.Onkologie. 2010; 33: 698
- Invasive lobular carcinoma of the male breast: a rare histology in an uncommon disease.Breast Care (Basel). 2009; 4: 36
- Lobular carcinoma of breast in an 85-year-old man.Eur J Surg Oncol. 2000; 26: 319
Surveillance, Epidemiology, and End Results (SEER) Program. Research data (1973–2008), www.seer.cancer.gov. National Cancer Institute, Division of Cancer Control and Population Services, Surveillance Research Program, Surveillance Systems Branch, released May 2011 [accessed].
- Marital status and stage at diagnosis of cutaneous melanoma: results from the Surveillance Epidemiology and End Results (SEER) program, 1973–2006.Cancer. 2011; 117: 1984
- Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.Breast Cancer Res. 2004; 6: R149
- Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.Am J Surg. 2006; 192: 552
- A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes.J Am Coll Surg. 1998; 186: 416
- Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patients.Breast Cancer Res Treat. 2011; 128: 429
- Survival analysis between patients with invasive ductal and invasive lobular breast cancer.Arch Gynecol Obstet. 2009; 279: 23
- Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.Am J Surg. 2009; 198: 516
- Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base.Ann Surg. 2005; 242: 281
- In situ breast cancer.Curr Treat Options Oncol. 2000; 1: 199
- Current treatment for lobular carcinoma in situ.Ann Surg Oncol. 1998; 5: 33
- Lobular carcinoma in situ: observation without surgery as an appropriate therapy.Ann Surg Oncol. 1994; 1: 141
- Lobular carcinoma in situ and invasive lobular cancer of the breast.Curr Opin Obstet Gynecol. 2005; 17: 55
- Trends in incidence rates of invasive lobular and ductal breast carcinoma.JAMA. 2003; 289: 1421
- Treatment of noninvasive carcinoma: fifteen-year results at the National Cancer Center Hospital in Tokyo.Breast Cancer. 2000; 7: 341
Published online: June 05, 2013
Accepted: May 9, 2013
Received in revised form: May 3, 2013
Received: January 5, 2013
© 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.